Neurotherapeutics Ltd received MHRA approval to use prototype clinical investigation devices in a new clinical study which will start in March 2022.
This study will investigate the impact of median nerve stimulation on reducing tics in individuals with Tourette syndrome.
Company number: 13198315
Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road
Nottingham
England
NG7 2TU
Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd